Even now, 65 percent of drugs being approved come from biopharma companies and, within a decade, that is expected to rise to 85 percent. This is excellent news for a world hungry for breakthrough treatments. As growth in pre-clinical and…
In recent years, social media has become an increasingly important source of clinical information for physicians and healthcare professionals. In 2020, ~73% of oncologists noted they were using social media as a clinical information source, with 28% and 45% indicating…
As we look forward to a future when face-to-face restrictions are lifted and in-person meetings and events are back in the game, we also recognize the strategic importance of digital collaboration and the possibilities that advanced communication platforms offer for…
From drab to fab, pharma social media promotions and campaigns are not only getting better but have gotten up to speed with the rest of the marketing world. That’s according to a panel of digital experts at Digital Pharma East this…
The drug sends a message to a caregiver after the patient swallows it. The doctor prescribes virtual reality treatments for migraines. Do you think it is science fiction? You are mistaken. The pharma industry has taken a big swung into…
Technologies such as simulation and VR can be used to help progress medical education and encourage enrolment and retention at further and higher education, as well as in GP and specialist training. In August this year, the NHS lost its…
Social media is among the most valuable channels by which pharmaceutical brands can reach healthcare decision-makers, drive engagement and build their businesses. However, there are a few key factors to keep in mind when building a social media strategy –…
Omnichannel marketing touts delivering efforts across all channels simultaneously, and looks to dethrone the incumbent multichannel marketing, but making the switch isn’t exactly easy. Omnichannel marketing is gaining traction within the pharmaceutical industry as a concept, replacing the current dominant…
The pharmaceutical industry is defined by constant change and evolution. This ever-changing nature of the industry, driven primarily by advances in therapies, medical devices and disease management, creates a constant demand for Pharma companies to educate healthcare professionals (HCPs), ensuring…
At this year’s Pharma USA conference, Collaboration was the theme of the opening keynote session and a common thread woven throughout the event as industry leaders gathered to discuss how to move “Beyond Normal” to shape the future of health.…
Omnichannel marketing has emerged as the solution to the growing pains that arise for pharmaceutical marketers as they strive to reach and engage customers. Faced with a challenging healthcare environment, as well as overwhelming, uncoordinated channel use and promotional waste,…
The line between the B2B and B2C customer experience is blurring, forever changed by the pandemic. Over the past year, the requirement to work from home has generated a shift in corporate behaviours, creating a less formal, more personal environment…
Telemedicine has played a key role during the COVID-19 pandemic, allowing non-urgent but vital care to be provided in the safety of a patient’s home, while hospitals and primary care centers focus on emergency treatment. While its benefits are clear…
Despite a wave of positive recognition at the start of the pandemic, public trust in hospitals and health systems has declined, according to Edelman’s annual Trust Barometer study. But the data also shows that the pharmaceutical industry continues to enjoy…
The gap between telehealth haves and have-nots threatens to undermine the momentum toward Pharma virtual care. Owing to a combination of stay-at-home orders and the federal government’s temporary expansion of coverage for telehealth services, COVID-19 catalyzed the adoption of telehealth.…
